DiaSorin, Inc. · Class I · Cleared Jan 5, 2017
| K-number | K162961 |
| Device name | LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control Set |
| Applicant | DiaSorin, Inc. |
| Product code | LSE |
| Device class | Class I |
| Decision date | Jan 5, 2017 |
| Decision | Substantially Equivalent |
| Regulation | 866.3235 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov